Product Information
GLYCOPYRROLATE 2 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1481 per EA under NDC 16571074409. Its NADAC has been published 259 times since Oct 20, 2021.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AA.
Strength
2 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571074409
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLYCOPYRROLATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA012827FDA Approved
Before 1982
TE Code
AA
On Market Since
10/6/2020
Pharmacological Classes
Price Statistics
The NADAC for GLYCOPYRROLATE 2 MG TABLET has been published 259 times since Oct 20, 2021, and over the history we have for it it has declined 52.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1481 per EA |
|---|---|
| All-time high | $0.3223 (Mar 16, 2022) |
| All-time low | $0.1444 (Nov 20, 2024) |
| 52-week high | $0.2419 |
| 52-week low | $0.1462 |
| Median price | $0.2201 |
| Average price | $0.2153 |
| Largest weekly change | +80.0% (Feb 23, 2022) |
| Weeks tracked | 259 |
| Tracking since | Oct 20, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glycopyrrolate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYCOPYRROLATE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 2 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1481 per EA (NDC 16571074409), effective Sep 30, 2026.
How has the price of GLYCOPYRROLATE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYCOPYRROLATE 2 MG TABLET has declined 52.1%. It has been tracked across 259 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 2 MG TABLET?
Since Oct 20, 2021, the NADAC for GLYCOPYRROLATE 2 MG TABLET has ranged from a low of $0.1444 (Nov 20, 2024) to a high of $0.3223 (Mar 16, 2022), with a median of $0.2201 per EA.
Are there cheaper alternatives to GLYCOPYRROLATE 2 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GLYCOPYRROLATE 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GLYCOPYRROLATE 2 MG TABLET?
GLYCOPYRROLATE 2 MG TABLET (NDC 16571074409) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.